NCT05603741View on ClinicalTrials.gov

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

November 10, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2027

Conditions
Ehlers-Danlos SyndromeAnesthesia, Local
Interventions
DRUG

0.9% Sodium Chloride Injection

All participants will be injected subcutaneously with a single 0.5ml dose

DRUG

Lidocaine Injection 2%

All participants will be injected subcutaneously with a single 0.5ml dose

Trial Locations (1)

T2N 4Z6

Cardiovascular Autonomic Research Lab, University of Calgary, Calgary

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

University of Calgary

OTHER